Pm. Schneider et al., MUTATIONS OF P53 IN BARRETTS-ESOPHAGUS AND BARRETTS-CANCER - A PROSPECTIVE-STUDY OF 98 CASES, Journal of thoracic and cardiovascular surgery, 111(2), 1996, pp. 323-331
We had previously identified p53 mutations in Barrett's esophagus and
therefore began a multiinstitutional study to determine their signific
ance as a marker for malignancy, Ninety-eight patients from four insti
tutions were studied, Forty-eight patients (37 men and 11 women, mean
age 56.2 years) had Barrett's esophagus with metaplasia or dysplasia b
ut no evidence of malignancy at a mean follow-up of 2.2 years, Barrett
's esophagus was classified as metaplasia with no evidence of dysplasi
a in 32 patients, as low-grade dysplasia in 13, and as high-grade dysp
lasia in three, The other 50 patients (46 men and four women, mean age
60.2 years) had adenocarcinoma arising in Barrett's esophagus, Tissue
s from normal stomach or esophagus, humor, and Barrett's esophagus wer
e obtained for deoxyribonucleic acid analysis by endoscopic biopsy fro
m patients with Barrett's esophagus or cancer or during operations on
some patients with Barrett's cancer, Exons 5 through 9 of the p53 gene
were studied for mutations by single-strand conformational polymorphi
sm analysis after polymerase chain reaction amplification, Mutations d
etected by single-strand conformational polymorphism analysis were con
firmed by deoxyribonucleic acid sequencing, None of the tissue samples
from patients with Barrett's esophagus alone and no dysplasia or low-
grade dysplasia had any p53 mutations, but one of the three patients w
ith high-grade dysplasia and no evidence of invasive malignancy did ha
ve a p53 mutation, Of the 50 patients with Barrett's cancer, however,
23 (46%) had p53 mutations in Barrett's epithelium, tumors, or both, T
wenty of these patients had p53 mutations in the tumor only (n = 16) o
r in both tumor and Barrett's epithelium (n = 4), suggesting that the
mutation plays a direct role in carcinogenesis, Mutations in Barrett's
epithelium were found in one patient in the group without malignancy
and in seven patients with cancer (one with no dysplasia, two with low
-grade dysplasia, and five with high-grade dysplasia), In three patien
ts with cancer, mutations occurred only in Barrett's epithelium, sugge
sting that such mutations may also be a marker for genomic instability
, Mutations were predominantly found in exons 5, 7, and 8, and transit
ions from guanine to adenine were the most frequent changes, Mutations
of p53 are clearly involved in the pathogenesis of Barrett's cancer f
or a subset of patients (46%), and the fact that we could detect mutat
ions in premalignant Barrett's epithelium supports the hypothesis that
p53 mutations may be a useful marker for patients at increased risk f
or development of invasive cancer.